Several new conditions have been approved by the Regulations Review Committee for medical marijuana in Connecticut on Tuesday.
The Regulations Review Committee of the General Assembly approved the new Department of Consumer Protection Medical Marijuana Program regulations.
The new regulations include five new conditions for adults and two new conditions for patients under 18, officials said.
For adults, interstitial cystitis, MALS syndrome (Median Arcuate Ligament Syndrome), vulvodynia and vulvar burning, intractable neuropathic pain that is unresponsive to standard medical treatments and Tourette Syndrome.
Patients under 18 can now use medical marijuana for intractable neuropathic pain that is unresponsive to standard medical treatments and Tourette Syndrome for patients who have failed standard medical treatment.
“I am pleased that more patients with severe debilitating conditions will now have medical marijuana as an option for treatment, and I look forward to continuing the Department’s work on this program,” said Consumer Protection Commissioner Michelle H. Seagull.
DCP must submit the regulations to the Secretary of the State's Office, who will post the new regulations online. Once they are posted, the regulations will be finalized.
There are currently more than 37,000 patients benefiting from the medical marijuana program in the state, authorities said.